Magellan Health (MGLN) Misses Q2 EPS by 6c, Revenues Beat, Announces CEO Succession Plan; 'Maintains FY19 Earnings Guidance Ranges'
Tweet Send to a Friend
Magellan Health (NASDAQ: MGLN) reported Q2 EPS of $0.86, $0.06 worse than the analyst estimate of $0.92. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
